While the chance of a blood clot from the J&J vaccine is astronomically low and vaccinating as many people as possible is a paramount goal, the government felt confident it could afford to stop its use.
New York, Connecticut, Massachusetts, New Hampshire, Rhode Island, Maryland, Virginia, Missouri, Georgia, Michigan and Ohio followed a recommendation by federal regulators Tuesday to temporarily pause Johnson & Johnson distribution after six reports of…
Uğur Şahin, cofounder and CEO of BioNTech, became a billionaire thanks to his company’s success in creating one of the first Covid-19 vaccines. Here the scientist talks about what’s next.